Regular Exercise or Changing Diet Does Not Influence Aortic Valve Disease Progression in LDLR Deficient Mice by Schlotter, Florian et al.
Regular Exercise or Changing Diet Does Not Influence









1University of Leipzig – Heart Center Leipzig, Department of Internal Medicine/Cardiology, Leipzig, Germany, 2Tohoku University Graduate School of Medicine,
Department of Cardiovascular Medicine, Sendai, Japan
Abstract
Background: The development and progression of calcific aortic valve disease (CAVD) shares a number of similarities with
atherosclerosis. Recently we could demonstrate that regular exercise training (ET) as primary prevention prevents aortic
valve disease in LDL-receptor deficient (LDLR
2/2) mice. We aimed to investigate the impact of exercise training on the
progression of CAVD in LDLR
2/2 mice in the setting of secondary prevention
Methods and Results: Sixty-four LDLR
2/2 mice were fed with high cholesterol diet to induce aortic valve sclerosis.
Thereafter the animals were divided into 3 groups: group 1 continuing on high cholesterol diet, group 2 continuing with
cholesterol diet plus 1 h ET per day, group 3 continuing with normal mouse chow. After another 16 weeks the animal were
sacrificed. Histological analysis of the aortic valve thickness demonstrated no significant difference between the three
groups (control 98.364.5 mm, ET 88.266.6 mm, change in diet 87.564.0). Immunohistochemical staining for endothelial
cells revealed a disrupted endothelial cell layer to the same extend in all groups. Furthermore no difference between the
groups was evident with respect to the expression of inflammatory, fibroblastic and osteoblastic markers.
Conclusion: Based on the present study we have to conclude that once the development of a CAVD is initiated, exercise
training or a change in diet does not have the potential to attenuate the progress of the CAVD.
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Introduction
Calcific aortic valve disease (CAVD) is a common medical
condition in the elderly – up to 25% of adults over 65 have
valvular sclerosis [1], and 2.8% of adults over 75 years old have
some degree of CAVD [2,3]. CAVD encompasses early sclerosis,
characterized by leaflet thickening, to late stenosis in which leaflets
stiffen, left ventricular outflow is obstructed, and cardiac function
is compromised. As a consequence CAVD sclerosis is associated
with a 50% increased risk of cardiovascular death and myocardial
infarction [4], and the prognosis for patients with stenosis is very
poor [5]. At present, no effective non-invasive therapy exists.
Valve replacement, the second-most frequent indication for
cardiac surgery [6], remains the only option to intervene, carrying
a perioperative mortality of about 3% [7]. CAVD and athero-
sclerosis exhibit a common pathophysiology [8] including endo-
thelial injury, macrophage infiltration and inflammation [9]. In
addition, epidemiological studies also confirmed that aortic
stenosis (AS) and atherosclerosis share several common risk
factors, like older age, diabetes, smoking, hypertension and
elevated levels of LDL [10]. For decades considered degenerative
in nature, nowadays understanding of AV sclerosis and subsequent
stenosis changed towards the perception of an active process that
can possibly be modified [8,11]. The early valvular changes
exhibited by aortic valve sclerosis are considered to be modifiable
by medical therapy in order to prolong the time until severe aortic
stenosis develops and to delay the timing of surgery [11]. Increased
physical activity proved effective in the prevention and treatment
of atherosclerosis [12]. It was thus an intriguing question to ask
whether exercise training (ET) would also be beneficial in stenotic
aortic valve disease too. Recent evidence suggests that exercise
training exerts its positive effects on calcific AV disease in the
setting of primary prevention by preservation of the valvular
endothelial cell layer, leading to a subsequent decrease in the
recruitment of inflammatory cells, oxidative stress and proosteo-
genic pathways [13]. No data exist so far showing that this therapy
is also effective in the setting of secondary prevention, which may
more resemble the daily clinical challenge. Therefore, aim of the
present study was to assess whether ET would be successful in
altering the progression of a preexisting sclerotic valvular lesion.
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Ethics Statement
All procedures were approved by the local council of animal
research (Regierungspra ¨sidium Leipzig, TVV 40/08).
Animals
A total of 64 low-density lipoprotein (LDL)-receptor-deficient
(LDLR
2/2) mice on the C57BL/6J background at the age of 4
weeks were fed with cholesterol rich diet until 20 weeks. At 20
weeks, the mice were randomly divided into 3 groups: group 1
(control group), cholesterol diet plus sedentary lifestyle, group 2
(exercise group), cholesterol diet plus exercise training (ET) (1 h/
day, 5 days/week), and group 3 (change of diet group), normal diet
plus sedentary lifestyle. At an age of 36 weeks the animals were
sacrificed by cervical dislocation and the tissue material was
harvested for further analyses (Figure 1).
The cholesterol-rich diet (Western-type diet) contained 0.15%
cholesterol and was obtained from Altromin GmbH (Lage,
Germany). The animals were housed at the Animal Research
Center of the University of Leipzig in a specific pathogen-free
environment in rooms with a 7 am to 7 pm light/dark cycle.
Training Protocol
Mice assigned to the ET group were taught to run on
a motorized rodent treadmill with a shock-plate incentive. The
slope of the treadmill was kept constant at 5u. Mice were trained at
a speed of 15 m/min for 60 min/day with 2-minute rest intervals
every 15 minutes, as described previously [13]. Except for the
exercise period in the training group, all of the mice were confined
to their cages throughout the study.
Morphometric and Immunohistochemical Analysis
The hearts were fixed in 4% formalin for 24 hours. After
fixation, the hearts were embedded into paraffin, and 4-mm serial
sections were cut through the AVs. Sections showing all 3 cusps
were stained with hematoxylin and eosin for general morphology.
Overall thickness of the leaflets was averaged over 5 equally
distributed length measurements per leaflet throughout the valve
and quantified with an imaging software (Analysis 3.0, Olympus
Soft Imaging Solutions GmbH, Mu ¨nster, Germany) as previously
described [13]. Immunohistochemistry for endothelial nitric oxide
synthase (eNOS) (rabbit polyclonal anti-mouse NOS-3 antibody,
Santa Cruz Biotechnology, Inc. Santa Cruz, USA), macrophages
(rat monoclonal antibody against mouse Mac3, BD Biosciences,
San Jose, USA), myofibroblast (a-smooth muscle actin (aSMA),
1A4, Sigma-Aldrich, Deisenhofen, Germany) and osteopontin
(rabbit polyclonal anti-osteopontin, Acris Antibodies, Herford,
Germany) was performed as previously described [13]. Endothe-
lial cell layer integrity and intensity of immunohistochemical
staining was quantified as previously described [13]. For
histochemical detection of angiotensin II receptor subtype 1
expression a specific antibody (Santa Cruz Biotechnology, Inc.
Santa Cruz, USA) was used a dilution of 1:200.
Mineralization was visualized by von Kossa staining as recently
described [13].
Functional Assessment of the Aortic Valve by
Echocardiography
To evaluate the AV function, echocardiographic assessment of
AV flow velocity was performed at the day of sacrifice. Trans-
thoracic echocardiography was performed with the Sonos 5500
echocardiogram (Agilent Technologies, Santa Clara, CA USA)
equipped with a 12-Mhz phased-array transducer. The anterior
thorax was shaved to optimize the acoustic interface. Warmed gel
was applied, and the animal was gently cradled in the left lateral
recumbent position. AV flow velocity was evaluated by continuous
waves recorded through a near apical approach, and 5 beats were
averaged. In 10 randomly selected mice, the inter-observer and
intra-observer variability for the measurement of AV flow velocity
were 3.761.1% and 1.960.3% respectively.
Blood Biochemical Analysis
Serum was collected from sacrificed animals and stored at
280uC for further analyses. Serum levels of total cholesterol were
determined enzymatically using a calorimetric assay kit (En-
zyChrom Cholesterol AssayKit, ECCH-100, Bioassay Systems,
Figure 1. Experimental study design. Four-week old LDLR
2/2 mice were fed cholesterol diet for 16 weeks. At week 20 all animals were
randomized into one of the following groups: Group 1 -control group- (cholesterol diet plus sedentary activity); group 2 –exercise training group-
(cholesterol diet plus exercise training); group 3 -change of diet group- (normal diet plus sedentary activity).
doi:10.1371/journal.pone.0037298.g001
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samples were assayed in duplicate.
RNA-Isolation and Quantitative Assessment of mRNA
Expression
AV cusps were scratched off from frozen sections on glass slides
under microscopic control and gene expression of BMP-2 and a-
smooth muscle actin was assessed as described earlier [13].
Superoxide Detection
To examine the involvement of oxidative stress in the AVs,
production of free radicals was evaluated using in situ dihy-
droethidium (DHE) fluorescence as previously described [13].
Briefly, frozen sections of aortic valves (30 mm) from the different
groups were incubated at the same time with DHE (10 mmol/L) in
PBS for 30 minutes at 37uC in a humidified chamber protected
from light. DHE is oxidized on reaction with O22 to ethidium
bromide, which binds to DNA in the nucleus and fluoresces red.
Tissue sections were then visualized with an Axioplan-2 fluores-
cence microscope (Zeiss, Oberkochen, Germany) equipped with
an Axio Cam MRC5 (Zeiss, Oberkochen, Germany). Frozen
sections from all groups were processed in parallel, and images
were acquired with identical acquisition parameters.
Sample-Size Calculation
The primary end point of the study was AV thickness at 36
weeks of age. To calculate the sample size, it was hypothesized on
the basis of a recent study [13] that AV thickness (mean6SD) of
the control, ET and change of diet groups was 80615 mm,
55615 mm and 55615 mm, respectively. Choosing a power of
90% and 5% type I error, we calculated that a sample size of at
least 8 animals in each subgroup would be required to detect
significant differences in AV thickness by ANOVA.
Statistical Analysis
SPSS version 16.0 (SPSS Inc, Chicago, Ill) was used for all of
the analyses. Data are expressed as mean6SEM. Comparisons
among groups were performed with ANOVA. When data were
not normally distributed or the variance was not equal, the
Kruskal-Wallis nonparametric test was applied. A value of p,0.05
was considered statistically significant. All of the measurements
were made by investigators blinded to the treatment group.
Results
Influence of Exercise Training on AV Diameter in
Secondary Prevention
Quantitative evaluation of AV diameter revealed that exercise
training over a period of 16 weeks had no significant effect on the
progression of AV thickening in secondary prevention in
comparison with the control group (control group 98.364.5 mm,
exercise group 88.266.6 mm; p=n.s.). Also in the ‘‘change in diet
group’’ receiving normal rodent chow from the age of 20 weeks,
no significant change in AV diameter progression was evident
when compared to the other 2 groups (change of diet group
87.564.0 mm) (Figure 2).
Effects of Exercise Training on Endothelial Cell Layer
Integrity
In the control animals 62.665.4% of the AV surface was
covered with endothelium as evident by eNOS-positive stained
cells. An exercise training program showed no significant impact
on the degree of endothelial cell coverage (exercise group
66.264.3%). The cholesterol-diet induced disruption of the
endothelial layer could also not be preserved significantly by
a change of diet (change in diet group 72.763.4%) (Figure 3).
Markers of Inflammation and oxidative stress
Immunostaining for Mac-3, a marker for the presence of
macrophages, was performed. Semi-quantitative analysis revealed
a high level of macrophage infiltration of the AV leaflets that was
almost identical among the three groups (Figure 4). Oxidative
stress levels were assessed by in-situ Dihydroethidium (DHE)
fluorescence. No significant difference in the degree of superoxide
expression was observed between the groups (data not shown).
Therefore, exercise training or a change in diet had no significant
impact on the inflammatory process or the load with reactive
oxygen species inside the AVs.
Influence on the Level of Pro-calcific Signaling
a-smooth muscle actin-positive myofibroblasts were abundant
inside the AVs of all three study groups. All AV leaflets showed
a high level of a-smooth muscle actin-positive cells demonstrating
fibrotic transformation. Semi-quantitative analysis revealed no
significant differences between the 3 groups (Figure 4). Analysis of
the m-RNA expression of a-smooth muscle actin confirmed the
results of the immunohistochemical analyses with no significant
differences observable between all study groups (control:
2.660.3 arb. units, exercise: 3.360.6 arb. units, change of diet:
3.161.3 arb. units; p=n.s.) (Figure 5A).
Moreover, osteopontin-positive cells could be detected in all
three study groups, demonstrating a high degree of osteoblast
differentiation (Figure 4). Semi-quantitative analysis exhibited no
significant differences between the 3 study groups. To confirm this
result, quantification of bone morphogenetic protein-2 by RT-
PCR was performed. There was also no significant difference
among the 3 groups (control: 17.364.8 arb. units, exercise:
22.664.4 arb. units, change of diet: 20.5610.7 arb. units;
p=n.s.) (Figure 5B). In addition, a weak staining for calcium
deposits using the von Kossa stain was evident in the thickened
part of the aortic valve leaflet (Figure 5C). Unfortunately
a quantification of the weak signal in all three groups was not
possible, while it was consistently positive over all the sections that
were stained.
Aortic Flow Velocity
Echocardiographic evaluations of maximum AV flow velocity at
the age of 20 and 36 weeks, revealed a significant increase in all 3
groups over time (control 20 weeks: 1.2660.06 m/s, control 36
weeks: 1.4360.06 m/s; exercise 20 weeks: 1.1860.03 m/s,
exercise 36 weeks: 1.3160.03 m/s; change of diet 20 weeks:
1.1160.02 m/s, change of diet 36 weeks: 1.2060.03 m/s).
However, comparing the increase in maximum AV flow velocity
over time (20 weeks vs. 36 weeks) showed no significant difference
between the 3 groups. A regular flow pattern was observed as
recently described [13].
Exercise Training Reduces AT1 Expression at AVs
The angiotensin II receptor type 1 (AT1), described as a further
element of the pathologic changes inside the AV leaflets, was
markedly down-regulated in its expression in those animals
receiving exercise training. Semi-quantitative analysis showed
a significantly lower expression of AT1 in the exercise group, while
AVs of the control group and change of diet group exhibited high
degrees of expression of AT1 (Figure 6).
Secondary Prevention of CAVD
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37298Effects on Body Weight and Lipid Metabolism
Analyzing the absolute change in body weight over the
intervention period of 16 weeks, revealed a significantly higher
increase in body weight in the control group, when compared to
the exercise and change of diet group (control: 7.3760.94 g;
exercise: 3.7060.46 g; change in diet: 3.6960.75 g; p,0.01).
ET for a period of 16 weeks in secondary prevention did not
significantly affect serum cholesterol levels in LDLR
2/2 mice fed
a cholesterol diet (control group 954.1668.5 mg/dL, exercise
group 1024.9688.8 mg/dL). In contrast the animals that un-
derwent a change in diet had markedly lower serum cholesterol
levels (change in diet group 315.7629.0 mg/dL).
Discussion
This study is the first to examine effects of exercise training on
the course of a preexisting sclerotic aortic valve lesion in a mouse
model (secondary prevention).
The following novel findings emerge from this study: On the
basis of a preexisting aortic valve sclerosis, ET or changing diet has
no influence on thickening of AV leaflets or the increase in aortic
flow velocity over time; ET or changing diet has no effect on
endothelial cell layer integrity; ET or changing diet has no
influence on molecular markers of inflammation and calcification.
The results of this study imply that AV sclerosis is a progressive
process and exercise training has no significant effects on disease
progression in secondary prevention.
Impact of Exercise Training on Morphologic and
Functional Features of the AV Leaflets
In a recent editorial Otto considers the direct evaluation of
tissue changes inside the AV leaflets the ideal end point for
measuring the effects of therapy [14]. Therefore, in our study the
AV leaflet thickness served as the primary end point. In contrast to
a primary prevention approach, as recently described by our
group [13], secondary prevention by exercise training was
ineffective in slowing down the progression of AV leaflet
thickening. Comparing the results of the AV thickness collected
in the present study, aiming at secondary prevention by ET, to
those measured by Matsumoto et al. targeting primary prevention
with the same ET program at an earlier intervention period [13],
we clearly see a further increase of AV leaflet diameter over time
(,50 mm after 16 weeks vs. ,90 mm after 32 weeks high
cholesterol feeding). Even removing the high concentration of
the atherogenic substrate cholesterol by changing the diet after the
induction of AV alterations could not halt or slow down the
progression of the morphological changes. These results are in
agreement with the recently published results from randomized
clinical studies using statins [15,16,17]. In one of these studies, the
treatment of asymptomatic patients with mild to moderate aortic
stenosis with rosuvastatin 40 mg did not reduce the progression of
AS despite a reduction in cholesterol levels [15]. The ineffective-
ness of both interventions, regular exercise training or changing
diet, to alter the progressive nature of AV stenosis is supported by
our functional measurements. Also by echocardiographic de-
termination of maximum AV flow velocity, no differences between
Figure 2. Tricuspid aortic valves (AVs) in LDLR
2/2 mice stained with hematoxylin-eosin (A). Arrowheads indicate sites of AV leaflets.
Bar=100 mm. Quantitative analysis of overall AV thickness in 10 animals from each group (B).
doi:10.1371/journal.pone.0037298.g002
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possible explanation of the negative result may be the in-
appropriate training duration. Nevertheless, in primary prevention
the same training protocol was very effective in preventing the
initiation of aortic valve sclerosis [13]. In addition, we could clearly
demonstrate an effect of the chosen training protocol on surrogate
markers like body weight and the valvular expression of
angiotensin II receptor type 1, which is known to be influenced
by exercise training [18].
Impact of Interventions on the Endothelium
The deterioration of the endothelial cell layer appears to be the
initializing lesion in calcified AV disease and facilitates the
activation of the pathologic cascade comprising macrophage
infiltration, oxidized lipid deposition, myofibroblast differentiation
and subsequent calcification [19]. The mechanical properties of
AVs are actively regulated by endothelium-dependent mediators,
such as NO and endothelin-1 through modulation of the
contractile potential of valve interstitial cells [20]. The matrix
stiffness of AVs determines the extend of calcific nodule formation-
as the basis of calcification [21]. In case of failure to adapt the
valve rigidity to different hemodynamic conditions, the resulting
turbulent flow could enforce further AV endothelial cell layer
alteration. Inability to restore endothelial integrity would thereby
lead to a vicious cycle consisting of continued and accelerated
inflammation, fibrosis and subsequent calcification. We have
recently shown that preservation of the endothelial integrity by
exercise training facilitates a conservation of the AV thickness
[13]. Exercise training in secondary prevention was ineffective in
restoring the endothelial cell layer in the present study and proved
to be unable to influence downward pathobiologic elements of the
disease process.
Independent from phenotypic variations between vascular and
valvular endothelial cells [22], the differences in microenviron-
ment between the one subtype that is exposed to laminar flow
conditions in the vasculature and the other that is subjected to
turbulent flow conditions at the aortic side of the valve could
provide an explanation for the differences in ET efficacy in
protecting the endothelial layer once pathologic changes have
occurred.
Impact on Secondary Outcome Measures
The level of macrophage infiltration, myofibroblast differenti-
ation, oxidative stress and osteoblast phenotypes remained high,
despite of exercise training or change in diet. These results
obtained by specific immunohistochemical staining were further
supported by quantifying the mRNA expression of BMP-2 (pro-
calcification) and a-SMA (myofibroblast). Taken together all of
these elements of the pathologic cascade leading to overt
thickening and calcification of the AVs are increased in all
subgroups of the present study and neither exercise training nor
changing the diet had any influence on these molecular markers.
Figure 3. Representative immunostaining for endothelial nitric oxide synthase (eNOS) in all three animal groups. (A) Cholesterol diet
plus sedentary activity (control group); (B) cholesterol diet plus exercise training; (C) normal diet plus sedentary activity. Quantitative analysis of
eNOS-positive circumference in 9 animals per group (D). Arrowheads indicate disrupted area of eNOS expression. Bar=100 mm.
doi:10.1371/journal.pone.0037298.g003
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after changing the diet of the animals after 16 weeks of Western
type diet. Unfortunately, this did not result in slowing down
disease progression. This is in contrast to a recently published
study by Miller and colleagues [23]. In their study they reported
that a significant reduction of the plasma cholesterol by knocking
down the microsomal triglyceride transfer protein halts the
progression of aortic valve stenosis. One possible explanation for
this difference might be the approach for reducing the cholesterol
level – genetic versus reduction of cholesterol intake.
It is well documented in the current literature, that components
of the renin-angiotensin-aldosteron system (RAAS) are expressed
at a higher level in stenotic aortic valves when compared to normal
valves [11,24,25]. In the present study we also could document
a robust expression of the AT1 receptor in the aortic valve leaflet
after cholesterol rich diet, which was significantly down-regulated
after 16 weeks of ET. Unfortunately, this exercise-induced
reduction in AT1 expression had no impact on disease pro-
gression. Therefore, one may speculate that modulating compo-
nents of the RAAS does not translate into a reduced progression of
the disease. This notion is supported by a study of O’Brien and
colleagues treating patients with mild to moderate AS with
ramipril [24]. In that small study no impact of ramipril treatment
on aortic jet velocity could be documented.
Possible Explanations for the Failure of Secondary
Prevention to Alter Disease Progression
As documented in the present study, the progression of AS can
not be altered either by ET or changing the diet, once initiated.
This finding is in line with the failure to provide conclusive
evidence on the restoration or attenuation of disease progress by
multiple pharmacological interventions like statins [15] or ACE
inhibitors [26].
Even though CAVD is considered an active, possibly modifiable
process, it remains an intriguing question to ask whether the tissue
changes are subject to a fixation at the molecular level and if there
is a putative point of no return as recently discussed by Sider and
colleagues [27]. This could in part be explained as recently
discussed [28] by epigenetic modification like methylation of key
genes of the molecular pathways of the pathologic cascade,
rendering any future intervention unsuitable to change the fate of
the disease process unless these modifications can be removed
from the promoter/enhancer/silencer regions of the genome of
the valvular cells. Another possible explanation would be that, as
discussed above, unfavorable flow conditions on the AV antici-
pating the known beneficial effect of ET on restoration of the
endothelial cell layer. Nevertheless, both hypotheses need further
molecular investigations.
Study Limitations
Several limitations of the present study should be mentioned.
Figure 4. Representative immunostainings for macrophages (Mac3), vascular smooth muscle cells and valvular myofibroblast-like
cells (a-smooth muscle actin [a-SMA]), and a phenotypic marker of osteoblast differentiation (osteopontin [OPN]) (A). Semi-
quantitative analysis of infiltration of macrophages (B), valvular myofibroblast-like cells (C), and osteoblast-type cells (D) in 9 animals from each group.
Arrowheads demonstrate areas of positive immunostaining at the vascular smooth muscle cell layer (a-SMA) and the atherosclerotic areas of the
aortic sinus (Mac3). Bar=100 mm.
doi:10.1371/journal.pone.0037298.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37298Figure 5. Quantitative analysis of messenger RNA expression for: a–smooth muscle actin, bone morphogenetic protein-2 (BMP-2,
a mediator of calcification) (B) from aortic valve cusps of 8 animals from each group. arb. Units=arbitrary units. An example of a von
Kossa staining is shown (C) (mineralization is shown as black dots).
doi:10.1371/journal.pone.0037298.g005
Figure 6. Representative immunostaining for angiotensin II receptor type 1 (AT1) in the control group, the cholesterol diet plus
exercise training group and the normal diet plus sedentary activity (A–C). Semi-quantitative analysis of AT1-positive cells in 8 animals from
each group (D). Arrowheads indicate positive staining of the endothelium serving as internal positive control. Bar=100 mm.
doi:10.1371/journal.pone.0037298.g006
Secondary Prevention of CAVD
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weeks is missing in the present study. So it may be difficult to make
some conclusions about the severity of the AV sclerosis. Neverthe-
less, based on our previous study [13], where animals were fed
with high cholesterol diet for 16 weeks, we see a clear progression
of AV sclerosis in the cholesterol fed group and no impact on AV
sclerosis by exercise training or changing diet, after the initiation
(16weeks) of sclerotic modifications. Second, a group starting
exercise training after 16 weeks cholesterol feeding and changing
back to normal mouse chow was not investigated in the study.
Based on the observation, that not even a trend towards slowing
disease progression by the single interventions was observed, we
speculated that a cumulative effect would also be negative.
Nevertheless, proof of this speculation needs further investigation.
Third, an evaluation of myocardial function either by echocar-
diography or invasive measurement after induction of AV sclerosis
and after finishing the intervention period is missing. Therefore,
we can not make any conclusion on changes in myocardial
performance after our interventions.
Conclusion
Based on the present study in a selected animal model we have
to conclude that once the initiation of the pathologic lesion is
completed, exercise training or a change in diet does not have the
potential to attenuate the progress of the AV disease process.
Therefore one may speculate that for clinical approaches
alternative therapeutic concepts to slow down the progression of
aortic valve disease should be explored.
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